For decades, the healing power of psychedelics in treating mental illness has been ignored, depriving over 700 million people worldwide of potentially life-changing therapeutics.

We are now at the dawn of a new scientific era.

Molecules like psilocybin, LSD, and DMT that have shown promise in treating psychiatric disorders are being revisited and researched.

And this resurgence is leading to a paradigm shift in public policy.

Cybin is at the forefront of this revolution.

Developing a new class of psychedelic medicine and treatment regimens. 

Navigating the brain’s intricate network into the next frontier.

With breakthrough science powered by cutting edge neurotechnology we’re quantifying what was previously impossible.

A critical loop between biofeedback and integration.

Unlocking one of humanity’s greatest mysteries.

We’re making new connections, opening pathways and possibilities for healing.

A complete transformation in mental health care.